IP Library Granted Patent US 8,522,778
Granted Patent B2
US 8,522,778 · App. 12/757,626 · Granted Sep 3, 2013

Nasal devices

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,522,778
App. No.
12/757,626
Granted
Sep 3, 2013
Kind
B2
Abstract

A nasal delivery device for and a method of delivering a substance to a nasal cavity of a subject, the delivery device including: a nosepiece for fitting to a nostril of a subject; a substance supply unit for supplying a substance for delivery through the nosepiece; and a delivery prevention mechanism for preventing delivery of a substance through the nosepiece until the nosepiece is properly fitted to the nostril of the subject.

Claims (13)

1. A nasal delivery device for delivering a substance to a nasal cavity of a subject, including:

a nosepiece for insertion into a nostril of a subject;

a mouthpiece through which the subject in use exhales;

a flow path fluidly which connects the nosepiece and the mouthpiece, whereby exhaled air from an exhalation breath is deliverable through the flow path;

a substance supply unit operable to supply a substance for delivery through the nosepiece; and

a delivery prevention mechanism configured to prevent exhalation through the flow path, wherein the delivery prevention mechanism comprises first and second members movable relative to one another between first and second configurations, one of the members defining at least a part of the flow path, and the other member including a blocking element which blocks the flow path when the first and second members are in the first configuration and opens the flow path when the first and second members are in the second configuration.

2. The delivery device of claim 1 , further including:

a biasing element for normally biasing the first and second members to the first configuration, whereby a predeterminable biasing force provided by the biasing element has to be overcome in moving the first and second members to the second configuration.

3. The delivery device of claim 1 , wherein the substance supply unit includes a dosing unit for supplying at least one substance.

4. The delivery device of claim 3 , wherein the dosing unit comprises a nebulizer for supplying an aerosol.

5. The delivery device of claim 3 , wherein the dosing unit comprises an aerosol canister for supplying an aerosol.

6. The delivery device of claim 3 , wherein the dosing unit comprises a delivery pump unit for supplying an aerosol, a liquid pump unit for supplying a liquid aerosol or a powder pump unit for supplying a powder aerosol.

7. The delivery device of claim 3 , wherein the dosing unit comprises a powder delivery unit for delivering a powder aerosol.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded May 21, 2025
From: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
To: OPTINOSE INC.
Reel/Frame 071547/0979 →
CHANGE OF ADDRESS Recorded Jan 6, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069825/0638 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2022
From: OPTINOSE AS
To: OPTINOSE INC
Reel/Frame 061546/0424 →
SECURITY INTEREST Recorded Sep 13, 2019
From: OPTINOSE AS
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 050371/0913 →
RELEASE OF SECURITY AGREEMENT RECORDED AT REEL 044976 FRAME 0505 Recorded Sep 13, 2019
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: OPTINOSE AS
Reel/Frame 050371/0894 →
SECURITY INTEREST Recorded Dec 29, 2017
From: OPTINOSE AS
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 044976/0505 →
CHANGE OF ADDRESS Recorded Apr 20, 2010
From: OPTINOSE AS
To: OPTINOSE AS
Reel/Frame 024258/0687 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2010
From: DJUPESLAND, PER GISLE
To: OPTINOSE AS
Reel/Frame 024239/0076 →